Atalanta Sosnoff Capital, LLC Gilead Sciences, Inc. Transaction History

Atalanta Sosnoff Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $240,838 - $273,116	3,287 New	3,287 $266,000
Q4 2022 Feb 09, 2023	BUY	$62.32 - $89.47 $3.12 Million - $4.48 Million	50,044 New	50,044 $4.3 Million
Q1 2019 Apr 09, 2019	SELL	$62.53 - $70.05 $23.7 Million - $26.6 Million	-379,219 Closed	0 $0
Q4 2018 Jan 09, 2019	SELL	$60.54 - $79.0 $2.15 Million - $2.81 Million	-35,508 Reduced 8.56%	379,219 $23.7 Million
Q3 2018 Oct 10, 2018	BUY	$71.28 - $78.92 $29.6 Million - $32.7 Million	414,727 New	414,727 $32 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Atalanta Sosnoff Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Atalanta Sosnoff Capital, LLC with notifications on news.